ofloxacin has been researched along with Leprosy, Cutaneous in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (63.64) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogra, S; Narang, T; Sakia, UN | 1 |
| Goyal, T; Sharma, V; Varshney, A; Zawar, V | 1 |
| Dave, S; Jayanthi, S; Nori, AV; Thappa, DM | 1 |
| Abalos, RM; Balagon, MV; Cellona, RV; Cruz, EC; Fajardo, TT; Gelber, RH; Villahermosa, LG | 1 |
| Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Singh, HB | 1 |
| Carli, P; Carloz, E; Carsuzaa, F; Chagnon, A; De Jaureguiberry, JP; Galzin, M; Marlier, S | 1 |
| Cree, IA; Lakshmipathi, T | 1 |
| Grosset, JH; Ji, B; N'Deli, L; Perani, EG; Petinom, C | 1 |
| Grosset, JH; Jamet, P; Ji, B; Lienhardt, C; Perani, EG; Petinon, C; Sow, S | 1 |
| Ramachandran, A; Rao, PS; Ravi, S; Sekar, B; Subramanian, M | 1 |
| Cambau, E; Guillemin, I; Jamet, P; Ji, B; Perani, E | 1 |
| Ishii, N; Koseki, M; Miyamoto, M; Nakajima, H; Sugita, Y | 1 |
| Ganapati, R; Gandewar, K; Pai, VV; Shroff, HJ | 1 |
| Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I | 1 |
| Abalos, RM; dela Cruz, EC; Fajardo, TT; Veerasubramanian, P; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
| Guglielmelli, E; Ishida, Y; Pecorini, L | 1 |
| Ebenezer, GJ; Job, CK | 1 |
| Andrade, AL; Costa, MB; Gillis, TP; Gomes, MK; Krahenbuhl, JL; Maroclo, AL; Martelli, CM; Narahashi, K; Nery, JA; Peninni, S; Rebello, PF; Sacchetim, SC; Salles, AM; Silva, SA; Stefani, MM | 1 |
| Biswas, SK; Hajra, SK; Majumder, V; Saha, B; Saha, K | 1 |
| Cavalcanti Neto, PF; Costa, MB; Gomes, MK; Maceira, JP; Martelli, CM; Narahashi, K; Pignataro, PE; Rebello, PF; Schettini, AP; Scollard, DM; Stefani, MM; Ueda, ES | 1 |
| Grosset, JH; Guelpa-Lauras, CC; Ji, BH; N'Deli, LN; Perani, EG | 1 |
| Cartel, JL; Chanteau, S; Grosset, JH; N'Deli, L; Perani, E; Roux, J | 1 |
9 trial(s) available for ofloxacin and Leprosy, Cutaneous
| Article | Year |
|---|---|
A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leprosy, Lepromatous; Male; Mycobacterium leprae; Ofloxacin; Pefloxacin; Philippines; Probability; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2004 |
Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Foot; Humans; Leprosy, Lepromatous; Male; Mice; Microbial Sensitivity Tests; Middle Aged; Mycobacterium leprae; Ofloxacin; Skin | 1994 |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin | 1996 |
Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
Topics: Adult; Animals; Anti-Infective Agents; Biopsy, Needle; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mice; Ofloxacin; Treatment Outcome | 1994 |
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Ofloxacin; Recurrence; Rifampin | 1997 |
Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Vaccines; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cohort Studies; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Neuritis; Ofloxacin; Rifampin | 2001 |
Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
Topics: Adolescent; Adult; Animals; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leprosy, Borderline; Leprosy, Lepromatous; Male; Mice; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Pefloxacin; Random Allocation | 1990 |
Relationships between PGL-1 antigen in serum, tissue and viability of Mycobacterium leprae as determined by mouse footpad assay in multibacillary patients during short-term clinical trial.
Topics: Animals; Antigens, Bacterial; Glycolipids; Humans; Immunoglobulin M; Leprosy, Lepromatous; Mice; Mycobacterium leprae; Ofloxacin; Pefloxacin; Skin | 1990 |
13 other study(ies) available for ofloxacin and Leprosy, Cutaneous
| Article | Year |
|---|---|
Persistent serpentine supravenous hyperpigmented eruption in lepromatous leprosy after minocycline.
Topics: Adult; Anti-Bacterial Agents; Clofazimine; Humans; Hyperpigmentation; Leprostatic Agents; Leprosy, Lepromatous; Male; Minocycline; Ofloxacin | 2015 |
A rare case of facial annular bullous erythema nodosum leprosum reaction in a young boy.
Topics: Adolescent; Anti-Infective Agents, Urinary; Drug Eruptions; Erythema Nodosum; Humans; Leprosy, Lepromatous; Male; Ofloxacin; Skin Diseases, Vesiculobullous; Urinary Tract Infections | 2016 |
A rare variant of erythema nodosum leprosum: a case report.
Topics: Abscess; Adult; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Macrophages; Male; Melanins; Minocycline; Mycobacterium tuberculosis; Neutrophils; Ofloxacin; Rifampin; Tumor Necrosis Factor-alpha; Vasculitis | 2003 |
Persister studies in leprosy patients after multi-drug treatment.
Topics: Adenosine Triphosphate; Adolescent; Adult; Anti-Bacterial Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin; Treatment Failure | 2005 |
[Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
Topics: Aged; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Ofloxacin; Recurrence; Rifampin | 1995 |
Successful treatment of multiple drug resistance with ofloxacin in a leprosy patient.
Topics: Aged; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leprosy, Lepromatous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Ofloxacin | 1995 |
Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Ofloxacin; Rifampin | 1997 |
Suppression of tumour necrosis factor-alpha expression in leprosy skin lesions during treatment for leprosy.
Topics: Aged; Anti-Infective Agents; Gene Expression; Humans; Immunohistochemistry; Leprosy, Lepromatous; Male; Ofloxacin; Polymerase Chain Reaction; Skin; Tumor Necrosis Factor-alpha | 1997 |
Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
Topics: Anti-Infective Agents; Communicable Disease Control; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Ofloxacin; Rifampin; Skin; World Health Organization | 1997 |
Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clofazimine; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Mycobacterium leprae; Ofloxacin; Skin; Treatment Outcome | 1999 |
A case of reconstruction of saddle nose deformity in leprosy.
Topics: Adult; Bone Transplantation; Communicable Disease Control; Drug Therapy, Combination; Female; Health Education; Humans; Leprostatic Agents; Leprosy, Lepromatous; Nose Deformities, Acquired; Ofloxacin; Plastic Surgery Procedures; Rhinoplasty; Rifampin; Treatment Outcome | 1999 |
Histopathological activity in paucibacillary leprosy patients after ROM therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Granuloma; Humans; Leprosy, Lepromatous; Male; Minocycline; Ofloxacin; Rifampin; Skin | 1999 |
Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy; Brazil; Child; Cohort Studies; Drug Therapy, Combination; Educational Status; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Selection; Rifampin | 2000 |